Clinical Oncology
Volume 16, Issue 8 , Pages 569-574, December 2004

A phase II study using retinoids as redifferentiation agents to increase iodine uptake in metastatic thyroid cancer

  • S.C. Short

      Affiliations

    • The Royal Marsden Hospital Thyroid Unit, London and Sutton, UK
    • Corresponding Author InformationAuthor for correspondence: Dr S. C. Short, Gray Cancer Institute, Mount Vernon Hospital, Northwood, Middlesex, UK. Tel: +44-1923-825433; Fax: +44-1923-835210.
    • ,
  • A. Suovuori

      Affiliations

    • The Royal Marsden Hospital Thyroid Unit, London and Sutton, UK
    • ,
  • G. Cook

      Affiliations

    • The Royal Marsden Hospital Thyroid Unit, London and Sutton, UK
    • ,
  • G. Vivian

      Affiliations

    • Department of Nuclear Medicine, Derriford Hospital, Plymouth, UK
    • ,
  • C. Harmer

      Affiliations

    • The Royal Marsden Hospital Thyroid Unit, London and Sutton, UK

Received 2 March 2004; received in revised form 9 June 2004; accepted 10 June 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0936-6555(04)00245-6

doi:10.1016/j.clon.2004.06.018

Clinical Oncology
Volume 16, Issue 8 , Pages 569-574, December 2004

Article Tools

* Image Usage & Resolution